Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Bullboard Posts
Comment by Stranius75on Jun 09, 2018 10:04pm
120 Views
Post# 28150863

RE:RE:RE:RE:RE:RE:Its been a bumpy ride to say the least

RE:RE:RE:RE:RE:RE:Its been a bumpy ride to say the leastA better comparison would be to compare WEED mkt cap of 8 billion ( yes BILLION ) to LDS 90 million mkt cap. That’s a multiple of 90x and LDS should have more revenue. Don’t take a rocket scientist to say LDS is incredibly undervalued.        
calenderj wrote: Weed.to made $11 million net profit on 200 million shares.LDS has 100 million shares out and expect to make $60 million in revenue with high margins by December.
     Think about that...if it all falls into place over the next month or two.We should have some numbers soon to validate what Brad has said or not.


Bullboard Posts